NasdaqGS:ILMNLife Sciences
A Fresh Look at Illumina (ILMN) Valuation Following the Launch of Protein Prep for Large-Scale Proteomics
Illumina (ILMN) just took the wraps off its Illumina Protein Prep, an innovative assay designed to make next-generation sequencing-based proteomics accessible at scale. For investors following the company's evolution in the genomics and life sciences space, this product launch is more than just another announcement; it marks wider access to a technology that could help drive new breakthroughs in cancer, cardiovascular, and immunologic research. With strong early customer feedback and...